Annals of Nuclear Medicine

Papers
(The H4-Index of Annals of Nuclear Medicine is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight82
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer51
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging47
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT31
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein30
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis29
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions21
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study20
A first-in-man PET study of 2-amino-[3-11C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers19
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients19
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study19
Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images18
Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation18
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras18
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?18
Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy17
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure16
0.071603059768677